Apoptosis
Apoptosis inhibitors are compounds that prevent or delay the process of programmed cell death, known as apoptosis. These inhibitors are vital in studying cell survival mechanisms and are used to investigate diseases where apoptosis is dysregulated, such as cancer, neurodegenerative disorders, and autoimmune diseases. By modulating apoptosis, these inhibitors can help in the development of therapies aimed at controlling cell death. At CymitQuimica, we provide a comprehensive selection of high-quality apoptosis inhibitors to support your research in cell biology, oncology, and related fields.
Subcategories of "Apoptosis"
- ASK(9 products)
- BCL(1 products)
- Caspase(154 products)
- FOXO1(2 products)
- IAP(67 products)
- Mdm2(12 products)
- PD-1/PD-L1(125 products)
- PDK(9 products)
- PERK(23 products)
- Serine/threonin kinase(17 products)
- Survivin(14 products)
- TNF(82 products)
- c-RET(61 products)
- p53(63 products)
Show 6 more subcategories
Found 6156 products of "Apoptosis"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
PI3K-IN-33
CAS:PI3K-IN-33 selectively inhibits PI3K-α/β/δ, blocks G2/M, induces apoptosis, for leukemia research.Formula:C23H21BrN6O2Color and Shape:SolidMolecular weight:493.36(1S,2S)-Bortezomib
CAS:(1S,2S)-Bortezomib (Bortezomib) is an enantiomer of Bortezomib.Formula:C19H25BN4O4Purity:99.6%Color and Shape:SolidMolecular weight:384.24Ref: TM-T10061
1mg60.00€2mg92.00€5mg160.00€10mg269.00€25mg429.00€50mg583.00€100mg783.00€1mL*10mM (DMSO)163.00€CGP74514A
CAS:CGP74514A, a CDK1 inhibitor with anticancer properties, triggers nearly 100% apoptosis in U937 cells within 24 hours.Formula:C19H25Cl2N7Color and Shape:SolidMolecular weight:422.36Rooperol
CAS:Rooperol: a norlignan with p38α inhibiting, immunomodulatory, antitumor, antibacterial, anticonvulsant, and antioxidant properties.Formula:C17H14O4Purity:98%Color and Shape:SolidMolecular weight:282.29PI3Kδ-IN-11
CAS:PI3Kδ-IN-11 is a potent and selective PI3Kδ inhibitor (IC50: 27.5 nM) that dose-dependently blocks PI3K/Akt pathway activity.Formula:C27H21N5OColor and Shape:SolidMolecular weight:431.492,3-DCPE
CAS:Induces p21, S-phase arrest in cancer cells through ERK pathways. IC50: 0.89 μM (LoVo cells), 12.6 μM (fibroblasts).Formula:C11H15Cl2NO2Purity:98%Color and Shape:SolidMolecular weight:264.15Anticancer agent 42
CAS:Oral anticancer 42 targets MDA-MB-231 cells; IC50 0.07μM; triggers apoptosis, enhances p53. Useful for metastatic breast cancer study.Formula:C19H16Cl2N2O3Color and Shape:SolidMolecular weight:391.25Trehalose 6-behenate
CAS:Trehalose 6-behenate is a Th1/Th17 skewing vaccine adjuvant.Formula:C34H64O12Purity:98%Color and Shape:SolidMolecular weight:664.86HJC0416
CAS:HJC0416 is a potent orally bioavailable signal transducer and activator of transcription 3 inhibitor.Formula:C18H17ClN2O4SPurity:98%Color and Shape:SolidMolecular weight:392.86PWT33597 mesylate
CAS:PWT33597 (VDC-597) is an oral PI3K alpha/mTOR dual inhibitor, potentially causing cancer cell death and growth inhibition.Formula:C27H34F2N8O7S2Color and Shape:SolidMolecular weight:684.7348BP-1-108
CAS:BP-1-108 is a potent and selective STAT5 inhibitor.Formula:C32H38N2O6SColor and Shape:SolidMolecular weight:578.72Topoisomerase II inhibitor 9
CAS:Topoisomerase II inhibitor 9: Topo II blocker (IC50: 0.97 μM), DNA intercalator (IC50: 43.51 μM), arrests G2/M in Hep G-2 cells and triggers apoptosis.
Formula:C22H17N7O3S2Color and Shape:SolidMolecular weight:491.55VO-OHPic
CAS:VO-OHPic, a selective PTEN inhibitor (IC50 = 46 nM), reduces apoptosis and inflammation in doxorubicin-induced cardiomyopathy.Formula:C12H10N2O8VColor and Shape:SolidMolecular weight:361.16BR102375
CAS:BR102375 is a non-TZD PPAR γ full agonist (EC50: 0.28 μM) for the treatment of type 2 diabetes.Formula:C31H34N6O4Purity:98%Color and Shape:SolidMolecular weight:554.64AD-2646
CAS:AD-2646 has antidepressant activity and inhibits 2-deoxy-D-glucose (2-DG)-induced gastric acid secretion.Formula:C23H40N2O4Color and Shape:SolidMolecular weight:408.57c-Met-IN-9
CAS:c-Met-IN-9 is a 4-phenoxypyridine derivative and a c-Met kinase inhibitor (IC50: 12 nM). c-Met-IN-9 induces apoptosis and shows antitumour effects.Formula:C25H19F2N5O3Color and Shape:SolidMolecular weight:475.45Anti-inflammatory agent 22
CAS:Compound 14a is an oral anti-inflammatory with an IC50 of 14.6 μM for TNF-α, preventing adipogenesis and reducing mouse limb lymphedema.Formula:C22H16O6Color and Shape:SolidMolecular weight:376.36PERK-IN-3
CAS:PERK-IN-3 is a potent inhibitor of PERK(IC50 of 7.4 nM).Formula:C22H16F2N4O2Purity:98%Color and Shape:SolidMolecular weight:406.38Bozepinib
CAS:Bozepinib is an antitumor compound that acts by inducing PKR-mediated apoptosis and synergizing with IFN.Formula:C20H14Cl2N6O5SPurity:98%Color and Shape:SolidMolecular weight:521.33ABN401
CAS:ABN401: potent c-MET inhibitor (IC50: 10 nM), cytotoxic to MET-dependent cancers, blocks tumor c-MET phosphorylation, for cancer research.Formula:C29H34N12OColor and Shape:SolidMolecular weight:566.66MI-1061
CAS:MI-1061 is a orally bioavailable inhibitor of MDM2 (MDM2-p53 interaction) (IC50=4.4 nM).Formula:C30H26Cl2FN3O4Color and Shape:SolidMolecular weight:582.45XMD15-44
CAS:XMD15-44, a RET kinase inhibitor, demonstrates potent growth-inhibitory effects on RAT1 cells transformed by RET/C634R and RET/M918T, with IC50 values of 11.5 nM and 8.3 nM, respectively. It effectively inhibits RET kinase activity and signaling in human thyroid cancer cell lines harboring oncogenic RET alleles, thereby reducing cell proliferation.Formula:C29H29F3N4OColor and Shape:SolidMolecular weight:506.56SDZ 224-015
CAS:SDZ 224-015 is an inhibitor of interleukin-1β (IL-1β) converting enzyme and caspase-1 with anti-COVID-19 and anti-inflammatory activity.Formula:C30H35Cl2N3O9Purity:95.49% - 95.49%Color and Shape:SolidMolecular weight:652.52CDK1/Cyc B-IN-1
CAS:CDK1/Cyc B-IN-1: Potent CDK1/Cyc B inhibitor, IC50 97 nM, induces apoptosis, arrests G2/M cycle, halts cancer growth.Formula:C14H12ClN3O2S2Color and Shape:SolidMolecular weight:353.85SMU127
CAS:SMU127 is an agonist of the toll-like receptor 1/2 (TLR1/2) heterodimer.Formula:C16H23N3O3SColor and Shape:SolidMolecular weight:337.44Zoledronate disodium
CAS:Zoledronate disodium inhibits osteoclasts, lowers bone turnover, stabilizes matrix, and has anti-tumor effects in osteosarcoma.Formula:C5H8N2Na2O7P2Color and Shape:SolidMolecular weight:316.0531C1A
CAS:C1A is an inhibitor of HDAC6 which modulates downstream autophagy substrates and leads to growth inhibition of a diverse set of cancer cell lines.Formula:C22H25Cl2N3O4SColor and Shape:SolidMolecular weight:498.42Ceranib-2
CAS:Ceranib-2, a ceramidase inhibitor (IC50: 28 μM, SKOV3), reduces sphingosine/S1P and promotes apoptosis, showing anticancer properties.
Formula:C25H19NO3Purity:98.49%Color and Shape:SolidMolecular weight:381.42BEPP monohydrochloride
CAS:BEPP monohydrochloride is a double-strand RNA-dependent protein kinase (PKR) activator.Formula:C23H24ClN3O2Color and Shape:SolidMolecular weight:409.91Antitumor agent-56
CAS:Antitumor-56: Oral triptolide derivative; inhibits melanoma; anti-tumor, anti-inflammatory, NO-releasing properties.Formula:C28H28N2O10SColor and Shape:SolidMolecular weight:584.59Mepazine acetate
CAS:Mepazine acetate is a MALT1 inhibitor.Formula:C21H26N2O2SColor and Shape:SolidMolecular weight:370.51Aurora A inhibitor 2
CAS:Aurora A inhibitor 2 (Compound 16h) is a potent inhibitor of Aurora A kinase (IC50: 21.94 nM).Formula:C24H26N6O3Color and Shape:SolidMolecular weight:446.5TSI-13-57
CAS:TSI-13-57 is a MyD88 inhibitor or pan-TLR inhibitor that suppresses MyD88 TIR domain dimerization ,inhibits LPS-induced TNF-α (IC50 = 6.73 mM).Formula:C28H29N3O3Purity:99.63%Color and Shape:SolidMolecular weight:455.55Arecaidine propargyl ester (hydrobromide)
CAS:Arecaidine propargyl ester: selective M2 muscarinic receptor agonist, induces guinea pig atrium contraction, lowers cat blood pressure, toxic to flies.Formula:C10H14BrNO2Color and Shape:SolidMolecular weight:260.13SGC-STK17B-1
CAS:SGC-STK17B-1 is a potent and selective inhibitor of STK17B/DRAK2 kinase.Formula:C16H10N2O2S3Color and Shape:SolidMolecular weight:358.46CAM 833
CAS:CAM 833 inhibits BRCA2-RAD51 interaction; Kd for ChimRAD51 is 366 nM, disrupts RAD51 oligocoagulation, and induces apoptosis in G2/M cells.Formula:C26H26ClFN4O5Purity:99.83%Color and Shape:SolidMolecular weight:528.96Mammea A/BA
CAS:Mammea A/BA combats T. cruzi by causing mitochondrial damage, ROS, DNA fragmentation, and vacuolization, leading to cell death. Useful for Chagas research.Formula:C25H26O5Color and Shape:SolidMolecular weight:406.47VU0285655-1
CAS:VU0285655-1, a PLD2 inhibitor, halts PLD2-deficient cell growth and protects against high glucose-induced cell death. Used in diabetic retinopathy research.Formula:C25H27N5O2Purity:99.73%Color and Shape:SolidMolecular weight:429.51Tubulin polymerization-IN-17
CAS:Compound 23g, a potent inhibitor of tubulin aggregation, induces apoptosis, and inhibits cell migration; promising for cancer research.Formula:C26H23NO5Color and Shape:SolidMolecular weight:429.46RO27-3225 TFA
CAS:RO27-3225, a MC4R agonist (EC50=1nM), may treat obesity and brain damage, also acts on MC1R, and helps in hemorrhagic shock.Formula:C41H53F3N12O8Color and Shape:SolidMolecular weight:898.9462AZD-5991 Racemate
CAS:AZD-5991 Racemate is the racemate of AZD-5991. (Rac)-AZD-5991 is a novel Mcl-1 inhibitor induces upregulation of BCL2,BCL-XL, CMYC and MCL1 in AML cell lines.Formula:C35H34ClN5O3S2Color and Shape:SolidMolecular weight:672.26IKK2-IN-4
CAS:IKK2-IN-4(IKK2 Inhibitor VI) is a highly potent IKK-2 inhibitor with an IC50 value of 25 nM. IKK2-IN-4 inhibited the production of TNF-α in PBMC induced by LPS.Formula:C12H11N3O2SPurity:99.83%Color and Shape:SolidMolecular weight:261.3Ref: TM-T36524
1mg108.00€5mg261.00€10mg401.00€25mg622.00€50mg837.00€100mg1,125.00€200mg1,504.00€500µg82.00€BN201
CAS:BN201 (OCS-05) is a neuroprotective drug by activating SGK2 and FOXO3 pathway. BN201 is able to regulate multiple kinases in the IGF1 pathway and cross BBB.Formula:C25H38FN5O4Purity:99.42% - 99.42%Color and Shape:SolidMolecular weight:491.6ABI-231 HCl
CAS:ABI-231: Oral tubulin inhibitor, IC50=5.2 nM for melanoma/prostate cancer, in clinical trials for prostate cancer, effective in vivo.Formula:C21H20ClN3O4Color and Shape:SolidMolecular weight:413.85(R)-STU104
CAS:(R)-STU104 is a TAK1-MKK3 protein-protein interaction (PPI) inhibitor. (R)-STU104 is a candidate compound for the treatment of ulcerative colitis.Formula:C18H18O4Purity:98.91% - 99.42%Color and Shape:SolidMolecular weight:298.33Ludartin
CAS:Ludartin activates TRPA1, induces DNA damage, and lowers mitochondrial potential, yielding anticancer effects.Formula:C15H18O3Color and Shape:SolidMolecular weight:246.3Vin-C01
CAS:Vin-C01, a potent protector of pancreatic β-cells (EC50=0.22μM), aids in type 2 diabetes research by preventing STZ-induced β-cell apoptosis.Formula:C20H24N2OColor and Shape:SolidMolecular weight:308.42Esuberaprost Sodium
CAS:Famitinib (SHR1020), an oral drug, inhibits c-kit, VEGFR-2, and PDGFRβ (IC50: 2.3/4.7/6.6 nM) and triggers apoptosis in gastric cancer.Formula:C23H27FN4O2Color and Shape:SolidMolecular weight:410.48SZM679
SZM679: Oral RIPK1 inhibitor, Kd 8.6 nM, weak RIPK3 affinity (>5000 nM). Reduces inflammation, Tau phosphorylation in AD research.Formula:C27H18F5N3O5SPurity:98%Color and Shape:SolidMolecular weight:591.51Oxythiamine chloride HCl
CAS:Oxythiamine chloride is a thiamine antagonist and anticancer agent that inhibits transketolase, affecting RNA/DNA synthesis and inducing apoptosis.Formula:C12H17Cl2N3O2SColor and Shape:SolidMolecular weight:338.25ARN 14494
CAS:ARN 14494, a potent SPT inhibitor (IC50=27.3 nM), reduces ceramide synthesis and neuroinflammation, and protects against β-amyloid toxicity.Formula:C24H32N4O3Color and Shape:SolidMolecular weight:424.54PHM16
CAS:PHM16 is an ATP competitive FAK and FGFR2 inhibitor.Formula:C20H22N6O4Purity:98%Color and Shape:SolidMolecular weight:410.43CGP 65015
CAS:CGP 65015 is an oral iron chelator and can mobilize iron deposits.Formula:C14H15NO4Purity:98%Color and Shape:SolidMolecular weight:261.27MYF-03-69
CAS:MYF-03-69, Covalent pan-TEAD inhibitor, inhibits transcriptional activity (IC50=56 nM), upregulates BMF, used for malignant pleural mesothelioma.Formula:C22H20F3N5O2Color and Shape:SolidMolecular weight:443.42Antiproliferative agent-11
Antiproliferative agent-11, a Ruthenium(II) complex, targets multiple cancers with IC50s of 6-10 μM.Formula:C31H34Cl2N6O3P2RuColor and Shape:SolidMolecular weight:772.56Targapremir-210
CAS:Targapremir-210 (TGP-210) is a miRNA-210 (miRNA-210) inhibitor that inhibits pre-miR-210 processing and induces apoptosis in breast cancer cells.Formula:C32H36N10O2Purity:98%Color and Shape:SolidMolecular weight:592.69CCCI-01
CAS:CCCI-01: Centrosome cluster inhibitor with anticancer properties, induces apoptosis, aids in non-cross-resistant drug research.Formula:C11H9N3O4Purity:99.97%Color and Shape:SolidMolecular weight:247.21RIP2 Kinase Inhibitor 3
CAS:RIP2 Kinase Inhibitor 3 is a potent and selective inhibitor of RIP2 with an IC50 of 1 nM.Formula:C19H24N4O3SPurity:99.32% - 99.52%Color and Shape:SolidMolecular weight:388.48PDE5-IN-3
CAS:PDE5-IN-3: Inhibits PDE5 (1.57 nM), EGFR (5.827 μM), Wnt pathway (1286.96 ng/mL), induces apoptosis, and has antitumor effects.Formula:C21H14BrN5O2Color and Shape:SolidMolecular weight:448.272'-Deoxyadenosine
CAS:2'-Deoxyadenosine (NSC-141848) is the DNA nucleoside A. It pairs with deoxythymidine (T) in double-stranded DNA.Formula:C10H13N5O3Purity:99.71%Color and Shape:SolidMolecular weight:251.24RIPK1-IN-15
CAS:RIPK1-IN-15 (Compound 2.5) is a potent RIPK1 inhibitor that has the potential in neurodegenerative, autoimmune, and inflammatory diseases research [1].Formula:C19H19N3O2Color and Shape:SolidMolecular weight:321.37ORY-1001 free base
CAS:ORY-1001: potent KDM1A inhibitor (IC50 <20nM), selective, affects THP-1 cell gene regulation and apoptosis, hinders MV(4;11) cell growth (EC50 <1nM).Formula:C15H22N2Purity:98%Color and Shape:SolidMolecular weight:230.35PAK4-IN-2
CAS:PAK4-IN-2 inhibits PAK4 with IC50 2.7 nM, arrests MV4-11 cells at G0/G1, and induces apoptosis, promising for cancer research.Formula:C18H21ClN6Color and Shape:SolidMolecular weight:356.85Butyrolactone I
CAS:Butyrolactone I (Olomoucin) inhibits CDKs, blocks cdc2 kinases, and shows antitumor activity in lung and prostate cancers.Formula:C24H24O7Purity:98%Color and Shape:SolidMolecular weight:424.44CN128 hydrochloride
CAS:CN128 hydrochloride is an oral, selective hydroxypyridone iron chelator for β-thalassemia research.
Formula:C15H18ClNO3Color and Shape:SolidMolecular weight:295.76RIP1 kinase inhibitor 6
CAS:RIP1 Kinase Inhibitor 6 is a potent and selective inhibitor of RIP1 kinase, demonstrating inhibitory activity with an IC50 of less than 100 nM in a human R1P1Formula:C19H18F2N2O3Purity:98%Color and Shape:SolidMolecular weight:360.35MSN-50
CAS:MSN-50, an inhibitor of Bax and Bak oligomerization, inhibits liposome permeabilization, prevents genotoxic cell death and promotes neuroprotection.Formula:C36H38BrN3O6Color and Shape:SolidMolecular weight:688.61IHMT-TRK-284
CAS:IHMT-TRK-284: Oral type II TRK inhibitor; targets TRKA, TRKB, TRKC (IC50s: 10.5, 0.7, 2.6 nM); selective and anti-tumor effective.Formula:C25H27N7OSColor and Shape:SolidMolecular weight:473.59ABD56
CAS:ABD56 inhibits osteoclast formation and activity in vitro and in vivo.Formula:C17H18O3Color and Shape:SolidMolecular weight:270.32CRA-026440
CAS:CRA-026440(PCI-34051) is a highly potent HDAC inhibitor with inhibitory effects on HDAC1, HDAC2, HDAC3, HDAC6, HDAC8 and HDAC10 with Ki values of 4,14,11,15,7Formula:C23H24N4O4Purity:96.42%Color and Shape:SolidMolecular weight:420.46BMS-242
CAS:BMS-242 is an effective inhibitor of PD-1/PD-L1 interaction.Formula:C28H35NO4Purity:98%Color and Shape:SolidMolecular weight:449.58DX2-201
CAS:DX2-201 is a potent and selective inhibitor of oxidative phosphorylation (OXPHOS) complex I (IC50: 312 nM) and exhibits anticancer activity.Formula:C18H28N2O6S2Color and Shape:SolidMolecular weight:432.55Semapimod
CAS:Semapimod is an inhibitor of proinflammatory cytokine production, capable of suppressing TNF-α, IL-1β, and IL-6.Formula:C34H52N18O2Color and Shape:SolidMolecular weight:744.9NHI-2
CAS:NHI-2 is an LDHA inhibitor (IC50 14.7 µM) that blocks glycolysis, induces apoptosis and cell cycle arrest, and suppresses tumor growth in melanoma models.Formula:C17H12F3NO3Purity:99.981%Color and Shape:SolidMolecular weight:335.28Fomesafen
CAS:Fomesafen (PP-021) is a diphenyl ether herbicide and an inhibitor of efficient and selective protoporphyrinogen IX oxidase (PPO).Formula:C15H10ClF3N2O6SPurity:99.91% - 99.93%Color and Shape:White Crystalline Solid Fomesafen Is A White Crystalline Solid Used As An HerbicideMolecular weight:438.76MEB55
CAS:MEB55, an anticancer agent, acts by disrupting DNA repair and halting growth in prostate, colon, lung and breast cancer cells.Formula:C22H17NO4SPurity:98%Color and Shape:SolidMolecular weight:391.44SB-218078
CAS:SB-218078 is less potently inhibits Cdc2 (IC50: 250 nM) and PKC (IC50: 1000 nM).Formula:C24H15N3O3Purity:98%Color and Shape:SolidMolecular weight:393.39Gea 3162
CAS:GEA 3162 blocks ADP-induced platelet clumping in PRP and boosts cGMP in granulocytes and leukocytes.Formula:C7H4Cl2N4OPurity:98%Color and Shape:SolidMolecular weight:231.04PI3K/AKT-IN-2
CAS:PI3K/AKT-IN-2 inhibits PI3K/AKT, EMT, induces apoptosis, and blocks tubulin polymerization.Formula:C32H27BrO10Color and Shape:SolidMolecular weight:651.45VMY-1-103
CAS:VMY-1-103: a strong CDK inhibitor better than purvalanol B; halts prostate/breast cancer cell growth, induces apoptosis, may treat medulloblastoma.Formula:C34H42ClN9O4SColor and Shape:SolidMolecular weight:708.27CPI-7c
CAS:CPI-7c inhibits MDM2-p53 interaction and promotes MDM2 degradation.Formula:C22H18N2O3Purity:98%Color and Shape:SolidMolecular weight:358.39SKLB70326
CAS:SKLB70326 is a cell-cycle progression inhibitor that acts by inducing G0/G1 phase arrest and apoptosis in human hepatic carcinoma cells.Formula:C15H13N3O2SPurity:98%Color and Shape:SolidMolecular weight:299.35DPQZ
CAS:DPQZ is an anti-tubulin compound acting by inducing cell apoptosis in human oral cancer cells through Ras/Raf inhibition and MAP kinases activation.Formula:C20H17N3OPurity:98%Color and Shape:SolidMolecular weight:315.37PS121912
CAS:PS121912 is a potent and selective inhibitor of VDR-coactivator.Formula:C24H21F3N2OPurity:98%Color and Shape:SolidMolecular weight:410.43AQX-016A
CAS:AQX-016A, a potent SHIP1 agonist, is an oral analog of pelorol, 3x stronger, inhibits PI3K, TNFa, for inflammation research.Formula:C22H32O2Color and Shape:SolidMolecular weight:328.49Pentabromophenol
CAS:Pentabromophenol (NSC-5717) suppressed TGF-β response by accelerating the turnover rate of TGF-β receptors.Formula:C6HBr5OPurity:99.83%Color and Shape:Monoclinic Prisms From Acetic Acid; Needles From Alcohol Physical Description Light Brown Powder Insoluble In Water (Ntp 1992)Molecular weight:488.59Anti-inflammatory agent 11
CAS:Potent anti-inflammatory compound 16 combats tuberculosis, inhibiting Mtb H37Rv and M299 (MICs: 1.3, 6.9 μM) and reduces NO, TNF-α, IL-1β production.Formula:C14H14N4OSColor and Shape:SolidMolecular weight:286.35K-7174 dihydrochloride
CAS:K-7174 dihydrochloride is a novel cell adhesion inhibitor; inhibits the expression of vascular cell adhesion molecule-1 (VCAM-1) induced by either IL-1β or TNF-Formula:C33H50Cl2N2O6Purity:99.15%Color and Shape:SolidMolecular weight:641.67ACA-28
CAS:ACA-28 is an ERK MAPK signalling modulator that induces apoptosis in melanoma cells by overexpressing ERK.Formula:C17H16O6Purity:98.73%Color and Shape:SolidMolecular weight:316.31Ref: TM-T60821
1mg101.00€5mg241.00€10mg382.00€25mg754.00€50mg1,238.00€100mg1,839.00€200mg2,489.00€1mL*10mM (DMSO)265.00€EAPB 02303
CAS:EAPB 02303, a microtubule inhibitor, induces mitotic arrest, spindle impairment, apoptosis, and has antitumor effects, enhancing Paclitaxel.Formula:C17H14N4O2Color and Shape:SolidMolecular weight:306.32Ro 31-7837
CAS:Ro 31-7837 is an opener of potassium channel.Formula:C17H16N2O2Color and Shape:SolidMolecular weight:280.32Caspase-3-IN-1
CAS:Caspase-3-IN-1 is a potent inhibitor of Caspase-3 (IC50: 14.5 nM).Formula:C26H25N3O6SColor and Shape:SolidMolecular weight:507.56Ozarelix
CAS:Ozarelix: a GnRH antagonist that induces apoptosis in advanced prostate cancer, modulates death receptors, and reduces sex hormones.Formula:C72H96ClN17O14Color and Shape:SolidMolecular weight:1459.09SS28
CAS:SS28 inhibits tubulin polymerization to cause cell cycle arrest at G2/M phase.Formula:C18H20O3Purity:98%Color and Shape:SolidMolecular weight:284.35TJ08
CAS:TJ08 has anticancer properties and can effectively induce G1/S phase blockade while promoting apoptosis in a variety of cancer cells.Formula:C22H16FN3O4Purity:99.89%Color and Shape:SolidMolecular weight:405.38EP12
CAS:EP12, a c-Myc inhibitor and G4 stabilizer, induces apoptosis and DNA damage in multiple myeloma cells while obstructing P65/P50 nuclear translocation byFormula:C26H22FN3O2Purity:98%Color and Shape:SolidMolecular weight:427.47673-A
CAS:673-A inhibits ALDH1A, depletes ovarian CSCs, induces necroptosis, and reverses chemo resistance.Formula:C15H13NOColor and Shape:SolidMolecular weight:223.27Telomerase-IN-4
CAS:Telomerase-IN-4 is a potent inhibitor of telomerase with antiproliferative properties and induces apoptosis [1].Formula:C21H18N4OS2Purity:98%Color and Shape:SolidMolecular weight:406.52Ac-IETD-CHO
CAS:Ac-IETD-CHO is a potent, reversible inhibitor of granzyme B and caspase 8, which also impedes Fas-mediated apoptosis, hemorrhagic conditions, and liver failure.Formula:C21H34N4O10Purity:98%Color and Shape:SolidMolecular weight:502.52
